Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr 5:7:124.
doi: 10.3389/fphys.2016.00124. eCollection 2016.

Poly Cystic Ovarian Syndrome: An Updated Overview

Samer El Hayek  1 , Lynn Bitar  1 , Layal H Hamdar  1 , Fadi G Mirza  2 , Georges Daoud  1
Affiliations
Review

Poly Cystic Ovarian Syndrome: An Updated Overview

Samer El Hayek et al. Front Physiol. .

Abstract

Poly Cystic Ovarian Syndrome (PCOS) is one of the most common metabolic and reproductive disorders among women of reproductive age. Women suffering from PCOS present with a constellation of symptoms associated with menstrual dysfunction and androgen excess, which significantly impacts their quality of life. They may be at increased risk of multiple morbidities, including obesity, insulin resistance, type II diabetes mellitus, cardiovascular disease (CVD), infertility, cancer, and psychological disorders. This review summarizes what the literature has so far provided from guidelines to diagnosis of PCOS. It will also present a general overview about the morbidities associated with this disease, specifically with its more severe classic form. Finally, the review will stress on the various aspects of treatment and screening recommendations currently used in the management of this condition.

Keywords: PCOS; diabetes; insulin; obesity; ovary.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Guidelines for the diagnosis of PCOS (Rotterdam, ; Azziz et al., 2006).
Figure 2
Figure 2
Signs and symptoms in patients with PCOS (Rotterdam, ; Chhabra et al., ; Legro et al., 2013).
See this image and copyright information in PMC

References

    1. Açbay O., Gündoğdu S. (1996). Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil. Steril. 65, 946–949. - PubMed
    1. Anderson H., Fogel N., Grebe S. K., Singh R. J., Taylor R. L., Dunaif A. (2010). Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J. Clin. Endocrinol. Metab. 95, 2180–2186. 10.1210/jc.2009-2651 - DOI - PMC - PubMed
    1. Arslanian S. A., Lewy V., Danadian K., Saad R. (2002). Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J. Clin. Endocrinol. Metab. 87, 1555–1559. 10.1210/jcem.87.4.8398 - DOI - PubMed
    1. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H. F., Futterweit W., et al. . (2006). Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237–4245. 10.1210/jc.2006-0178 - DOI - PubMed
    1. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H. F., Futterweit W., et al. . (2009). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456–488. 10.1016/j.fertnstert.2008.06.035 - DOI - PubMed

LinkOut - more resources